Stock listing

REC Stock Price, News, Filings & Events — Recordati S.p.a.

Selected listing: REC · MIL · EUR · IT

This page tracks Recordati S.p.a.'s REC:MIL listing on MIL in EUR for IT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following REC:MIL. REC:MIL is the stock-level entry point for investors researching Recordati S.p.a., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Recordati S.p.A. is a public company based in Italy, listed under the ticker REC. With a market capitalization of approximately €12.14 billion, Recordati focuses on the development and commercialization of pharmaceuticals. The company is well-established in the healthcare sector, providing a range of products to improve patient health.

REC:MILEURITUpdated August 22, 2026
Recordati S.p.a. logo
Ticker
REC:MIL
Asset type
Stock
Market cap
$12.77B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
MIL
Currency
EUR

Recordati S.p.a. REC:MIL stock context

This page tracks Recordati S.p.a.'s REC:MIL listing on MIL in EUR for IT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following REC:MIL. REC:MIL is the stock-level entry point for investors researching Recordati S.p.a., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Recordati S.p.A. is a public company based in Italy, listed under the ticker REC. With a market capitalization of approximately €12.14 billion, Recordati focuses on the development and commercialization of pharmaceuticals. The company is well-established in the healthcare sector, providing a range of products to improve patient health.

Latest news from Recordati S.p.a.

All Recordati S.p.a. news →

Recordati S.p.a. earnings calls

Research Recordati S.p.a.

Alternate listings